MedTrace Logo

Role of Interleukin-1 in Postprandial Fatigue - The Cheesecake Study

NCT01810549 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2014-12-17

No results posted yet for this study

Summary

The aim of the study is to investigate, if postprandial fatigue symptoms after ingestion of a high-fat, high-carbohydrate meal are regulated by Interleukin (IL)-1 and can be prevented by inhibition of IL-1 using a single dose injection of a specific IL-1 receptor antagonist.

Conditions

  • Postprandial Fatigue

Interventions

DRUG

Anakinra

Each subject will receive one single subcutaneous injection of 100mg Anakinra during the study, a total of one injection.

DRUG

Placebo

Every subject will receive one single subcutaneous injection of Placebo during the study, a total of one injection.

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Marc Y Donath, Prof. · Univesity Hospital Basel

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01810549 on ClinicalTrials.gov